Table I.
HA-1 Gene Expression in Tumor Cell Lines
| Tumor type | Cell line | HA-1 percentagea |
|---|---|---|
| Breast cancer | ZR75-1 | 54 |
| BT-20 | 40 | |
| 734B | 27 | |
| T47 D | 17 | |
| MDA-MB231 | 15 | |
| MCF-7 | ≤10 | |
| BT 474 | ≤10 | |
| Melanoma | Mel 93.04 | 68 |
| KUL 68/3636 | 67 | |
| BB 74/2940 | 57 | |
| MNT | 27 | |
| LB33 | 24 | |
| BT | 15 | |
| 453 Ao | 12 | |
| 518A | ≤10 | |
| E9 | ≤10 | |
| MEWO | ≤10 | |
| Lung carcinoma | GLC 36 | 22 |
| GLC 8 | ≤10 | |
| GLC 2 | ≤10 | |
| Renal cell carcinoma | MZ 1851 | 29 |
| MZ 1752 | 13 | |
| MZ 1774 | ≤10 | |
| BA | ≤10 | |
| Hepatoma | HuH7 | 37 |
| HepG2 | 35 | |
| Colon carcinoma | SW 707 | 147 |
| CaCo-2 | 81 | |
| SW 480 | 70 | |
| SW 2219 | 48 | |
| SW 620 | 28 | |
| Col 205 | 21 | |
| SW 948 | 12 | |
| HT29 | 11 | |
| Head and neck cancer | BB 49/1413 | 54 |
a
The percentage of CD45 gene expression was ≤10 for all of the samples tested.